The Apolipoprotein E (APOE) gene plays a significant role in Alzheimer's disease and dementia. It encodes a protein involved in lipid transport and neurorepair in the brain. There are three common forms of the APOE gene: APOE ε2, APOE ε3, and APOE ε4. Of these, APOE ε4 is the most established genetic risk factor for late-onset Alzheimer's disease. Individuals who inherit one copy of APOE ε4 have an increased risk, while those with two copies have an even higher risk. APOE ε4 is thought to contribute to Alzheimer's by influencing amyloid beta aggregation and clearance, as well as neuroinflammation and neuronal injury. Understanding the role of APOE in Alzheimer's helps in identifying those at higher risk and developing targeted therapies aimed at delaying or preventing the onset of the disease.
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia